Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Phathom Pharmaceuticals, Inc. (PHAT) had Debt to Equity Ratio of -0.48 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$57.58M |
|
$-21.15M |
|
$7.65M |
|
$49.94M |
|
$63.51M |
|
$-5.93M |
|
$-15.22M |
|
$-21.15M |
|
$-21.15M |
|
$-21.15M |
|
$-21.15M |
|
$-21.15M |
|
$-21.15M |
|
$-5.93M |
|
$-4.99M |
|
72.92M |
|
72.92M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$228.97M |
|
$1.06M |
|
$30.18M |
|
$259.15M |
|
$132.04M |
|
$209.09M |
|
$565.27M |
|
$697.32M |
|
$-438.17M |
|
$-438.17M |
|
$-438.17M |
|
71.42M |
|
| Cash Flow Statement Financials | |
$-166.78M |
|
$-0.23M |
|
$-0.29M |
|
$300.12M |
|
$132.83M |
|
$-167.29M |
|
$28.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.73 |
|
-- |
|
-- |
|
-0.91 |
|
|
Debt to Equity Ratio |
-0.48 |
86.72% |
|
-10.29% |
|
-10.29% |
|
-- |
|
-36.73% |
|
-36.73% |
|
$-167.00M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
1.39 |
|
0.74 |
|
122.11 |
|
4.83% |
|
4.83% |
|
-8.16% |
|
9.23% |
|
$-6.14 |
|
$-2.29 |
|
$-2.29 |
|